What Next25 Mar 2023 11:17
I agree totally with IWTO's comments...AVO, over the past months, must have recognised the short term funding issues but failed to raise these to support the monthly operational costs through to accreditations and the first patient treatments. One assumes this could have been achieved with relative ease rather than the limited "drip drip" funding put in place. Raising the prospect of needing £50M to £70M in these turbulent markets based on the lack of fiscal strategy to date, has spooked the markets and as time now is so short to running out of cash to support operational costs they are caught between a rock and a hard place. It would appear that the sp on AIM is tied no longer to the volume of trades but on the prospect of their raising the required funds in the short term. The sp dropping 10% of its value yesterday based on recent trades is ludicrous.